Schedule 13D ownership disclosure
Paratek Pharmaceuticals Inc
Security class unavailable · CUSIP: 699374302
Event date: 2016-06-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.2600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-17-078114
- Form type
- SC 13D
- Filer
- Omega Fund III, L.P.
- CIK
- CIK 1403748
- Filed
- Mar 10, 2017
- Reporting period
- Jun 27, 2016
- Description
- Schedule 13D beneficial ownership